Pancreatic Islet Cell Carcinoma
Also known as: Malignant neoplasm of islets of Langerhans / Carcinoma, Islet Cell / Islet Cell Carcinoma / Malignant neoplasm of endocrine pancreas / Malignant pancreatic islet neoplasm / Pancreatic islet cell neoplasm malignant NOS / Islet cell carcinoma (morphologic abnormality) / Malignant tumor of Islets of Langerhans (disorder) / Carcinoma of endocrine pancreas (disorder) / Primary malignant neoplasm of islets of langerhans (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11702 | Antineoplaston A10 | 2 | Withdrawn | 1 |
DB01101 | Capecitabine | 2 | Active Not Recruiting | 1 |
DB01590 | Everolimus | 2 | Completed | 2 |
DB00099 | Filgrastim | 2 | Terminated | 1 |
DB00104 | Octreotide | 2 | Completed | 2 |
DB00104 | Octreotide | 2 | Withdrawn | 1 |
DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
DB04879 | Vatalanib | 2 | Withdrawn | 1 |
DB01268 | Sunitinib | 3 | Terminated | 1 |
DB01268 | Sunitinib | Not Available | Completed | 1 |